Eli Lilly's Mirikizumab Improves Fatigue in Crohn's Disease Patients

  • As a part of a pre-specified analysis of the Phase 2 SERENITY study, new data showed that Eli Lilly And Co's LLY mirikizumab improved fatigue in patients with moderately to severely active Crohn's disease (CD) at 12 weeks. Improvements were sustained up to one year.
  • The results were presented at Digestive Disease Week.
  • "New data show that fatigue is more than a symptom of ulcerative colitis and Crohn's disease. It can also be an important predictor for the severity of a person's disease", said the lead author of these analyses.
  • In SERENITY, patients treated with mirikizumab saw improved fatigue during the induction period of 12 weeks from baseline compared to placebo.
  • Mirikizumab is a humanized IgG4 monoclonal antibody that binds to the p19 subunit of interleukin 23.
  • Last month, the company scrapped its plans to seek approval for mirikizumab in psoriasis.
  • Price Action: LLY shares closed at $199.88 on Friday.

Posted In: BriefsCrohn's DiseaseBiotechNewsHealth CareFDAGeneral

Ad Disclosure: The rate information is obtained by Bankrate from the listed institutions. Bankrate cannot guaranty the accuracy or availability of any rates shown above. Institutions may have different rates on their own websites than those posted on Bankrate.com. The listings that appear on this page are from companies from which this website receives compensation, which may impact how, where, and in what order products appear. This table does not include all companies or all available products.

All rates are subject to change without notice and may vary depending on location. These quotes are from banks, thrifts, and credit unions, some of whom have paid for a link to their own Web site where you can find additional information. Those with a paid link are our Advertisers. Those without a paid link are listings we obtain to improve the consumer shopping experience and are not Advertisers. To receive the Bankrate.com rate from an Advertiser, please identify yourself as a Bankrate customer. Bank and thrift deposits are insured by the Federal Deposit Insurance Corp. Credit union deposits are insured by the National Credit Union Administration.

Consumer Satisfaction: Bankrate attempts to verify the accuracy and availability of its Advertisers' terms through its quality assurance process and requires Advertisers to agree to our Terms and Conditions and to adhere to our Quality Control Program. If you believe that you have received an inaccurate quote or are otherwise not satisfied with the services provided to you by the institution you choose, please click here.

Rate collection and criteria: Click here for more information on rate collection and criteria.